Novel carcinoma-specific monoclonal antibodies for therapies and diagnostics
Ended Project Grant Awarded Last action
- Award ID
- R43CA235813
- Recipient
-
Recodagen LLC UEI F935QATX87K3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R43CA235813?
R43CA235813 was awarded to Recodagen LLC by National Cancer Institute (National Institutes of Health) on March 13, 2019.
How much is award R43CA235813 worth?
$300,000 has been obligated on R43CA235813.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award